Manuscripts

Search by keyword, year, or author name.

Showing 1552 manuscripts.

Safety and Immunogenicity of a Heptavalent Pneumococcal Conjugate Vaccine in Infants with HIV Type-1 Infection

Sharon Appelbaum Nachman, James King, Elaine J. Abrams, David Margolis, Ann Petru, William T. Shearer, Elizabeth Smith, John ( Jack ) Moye, Suzette Blanchard, Elizabeth Hawkins, Pamela Bouquin, Peter Eugene Vink, Mindy Benson, Scharla Estep, F. Maloniski. Safety and Immunogenicity of a Heptavalent Pneumococcal Conjugate Vaccine in Infants with HIV Type-1 Infection. Pediatrics. 2003. 112: 66-73.

Year

2003

Journal

Pediatrics

Population Pharmacokinetics and Pharmacodynamics of Zidovudine in HIV-infected Infants and Children.

Edmund Capparelli, Janet Ailene Englund, James D. Connor, Stephen A. Spector, Ross E. McKinney, Paul Palumbo, Paul Palumbo, Carol J. Baker, Carol J. Baker. Population Pharmacokinetics and Pharmacodynamics of Zidovudine in HIV-infected Infants and Children.. Journal of Clinical Pharmacology. 2003. 43: 133-140.

Year

2003

Journal

Journal of Clinical Pharmacology

Normal Distribution of Peripheral Blood Mononuclear Cell (PBMC) Subsets from Birth to 18 years: The NIH NIAID DAIDS Pediatric AIDS Clinical Trials group P-1009 Protocol.

William T. Shearer, Howard Max Rosenblatt, Stephen A. Spector, E. Richard Stiehm, E. Richard Stiehm, Diane W. Wara, Steven D. Douglas, Katherine Luzuriaga, Elizabeth (Betsy) J. McFarland, Ram Yogev, Mobeen H. Rathore, Wende Levy, Bobbie L. Graham, Rebecca Oyomopito, Rebecca S. Gelman. Normal Distribution of Peripheral Blood Mononuclear Cell (PBMC) Subsets from Birth to 18 years: The NIH NIAID DAIDS Pediatric AIDS Clinical Trials group P-1009 Protocol.. Journal of Allergy and Clinical Immunology. 2003. s271.

Year

2003

Journal

Journal of Allergy and Clinical Immunology

Nelfinavir Pharmacokinetics in Stable Human Immunodeficiency Virus-Positive Children: Pediatric AIDS Clinical Trials Group Protocol 377

Leslie Carstensen Floren, Andrew A. Wiznia, Sandra Hayashi, Anura L. Jayewardene, Kenneth Stanley, George M. Johnson, Sharon Appelbaum Nachman, Paul Krogstad, Francesca Aweeka. Nelfinavir Pharmacokinetics in Stable Human Immunodeficiency Virus-Positive Children: Pediatric AIDS Clinical Trials Group Protocol 377. Pediatrics. 2003. 112: e220-e227.

Year

2003

Journal

Pediatrics

Accuracy of the TRUGENE HIV-1 genotyping kit

Robert M. Grant, Daniel R. Kuritzkes, Victoria A. Johnson, John W. Mellors, John L. Sullivan, Ronald Swanstrom, Richard T. D'Aquila, Mark Van Gorder, Mark Holodniy, Robert M. Lloyd, Caroline Reid, Gillian F. Morgan, Dean L. Winslow. Accuracy of the TRUGENE HIV-1 genotyping kit. Journal of Clinical Microbiology. 2003. 41: 1586-93.

Year

2003

Journal

Journal of Clinical Microbiology

Enfuvirtide, an HIV-1 fusion inhibitor, for drug-resistant HIV infection in North and South America

John Delehanty, Miklos P. Salgo, Jay Lalezari, W. Keith Henry, Mary O'Hearn, Julio S.G. Montaner, Peter J. Piliero, Benoit Trottier, Sharon Lynn Walmsley, Calvin J. Cohen, Daniel R. Kuritzkes, Joseph J. Eron, Jain Chung, Ralph A. DeMasi, Lucille Donatacci, Claude Drobnes. Enfuvirtide, an HIV-1 fusion inhibitor, for drug-resistant HIV infection in North and South America. New England Journal of Medicine. 2003. 384: 2175-85.

Year

2003

Journal

New England Journal of Medicine

Factors associated with oropharyngeal human immunodeficiency virus shedding

Richard A. Zuckerman, William L.H. Whittington, Connie Celum, Tarquin Collis, Aldo J. Lucchetti, Jorge L. Sanchez, James P. Hughes, Robert W. Coombs. Factors associated with oropharyngeal human immunodeficiency virus shedding. Journal of Infectious Diseases. 2003. 188: 142-5.

Year

2003

Journal

Journal of Infectious Diseases

GB virus type C/hepatitis G virus: a non-pathogenic flavivirus associated with prolonged survival in HIV-infected individuals

Philip M. Polgreen, Jinhua Xiang, Qing Chang, Jack T. Stapleton. GB virus type C/hepatitis G virus: a non-pathogenic flavivirus associated with prolonged survival in HIV-infected individuals. Microbes and Infection. 2003. 5: 1255-61.

Year

2003

Journal

Microbes and Infection

Enfuvirtide (T-20) cross-reactive glycoprotein 41 antibody does not impair the efficacy or safety of enfuvirtide

Sharon Lynn Walmsley, W. Keith Henry, Christine Katlama, Mark Nelson, Antonella Castagna, Jacques Reynes, Bonaventura Clotet, James Hui, Miklos P. Salgo, Ralph A. DeMasi, John Delehanty. Enfuvirtide (T-20) cross-reactive glycoprotein 41 antibody does not impair the efficacy or safety of enfuvirtide. Journal of Infectious Diseases. 2003. 188: 1827-33.

Year

2003

Journal

Journal of Infectious Diseases